Ramucirumab
CAS 1231929-97-7 1 FDA-DMF supplierBiologic
Overview
Ramucirumab is a monoclonal antibody used as a cancer treatment, specifically used primarily for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma. It works by inhibiting angiogenesis, blocking the VEGFR-2 receptor, thereby hindering cancer cell growth and proliferation.
Therapeutic areas
OncologyGastrointestinal disorders
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.